ChlVPP-EVA regimen: Difference between revisions

	WikiDoc Resources for ChlVPP-EVA regimen
Articles
Most recent articles on ChlVPP-EVA regimen Most cited articles on ChlVPP-EVA regimen Review articles on ChlVPP-EVA regimen Articles on ChlVPP-EVA regimen in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on ChlVPP-EVA regimen Images of ChlVPP-EVA regimen Photos of ChlVPP-EVA regimen Podcasts & MP3s on ChlVPP-EVA regimen Videos on ChlVPP-EVA regimen
Evidence Based Medicine
Cochrane Collaboration on ChlVPP-EVA regimen Bandolier on ChlVPP-EVA regimen TRIP on ChlVPP-EVA regimen
Clinical Trials
Ongoing Trials on ChlVPP-EVA regimen at Clinical Trials.gov Trial results on ChlVPP-EVA regimen Clinical Trials on ChlVPP-EVA regimen at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on ChlVPP-EVA regimen NICE Guidance on ChlVPP-EVA regimen NHS PRODIGY Guidance FDA on ChlVPP-EVA regimen CDC on ChlVPP-EVA regimen
Books
Books on ChlVPP-EVA regimen
News
ChlVPP-EVA regimen in the news Be alerted to news on ChlVPP-EVA regimen News trends on ChlVPP-EVA regimen
Commentary
Blogs on ChlVPP-EVA regimen
Definitions
Definitions of ChlVPP-EVA regimen
Patient Resources / Community
Patient resources on ChlVPP-EVA regimen Discussion groups on ChlVPP-EVA regimen Patient Handouts on ChlVPP-EVA regimen Directions to Hospitals Treating ChlVPP-EVA regimen Risk calculators and risk factors for ChlVPP-EVA regimen
Healthcare Provider Resources
Symptoms of ChlVPP-EVA regimen Causes & Risk Factors for ChlVPP-EVA regimen Diagnostic studies for ChlVPP-EVA regimen Treatment of ChlVPP-EVA regimen
Continuing Medical Education (CME)
CME Programs on ChlVPP-EVA regimen
International
ChlVPP-EVA regimen en Espanol ChlVPP-EVA regimen en Francais
Business
ChlVPP-EVA regimen in the Marketplace Patents on ChlVPP-EVA regimen
Experimental / Informatics
List of terms related to ChlVPP-EVA regimen

Newer edit →

VisualWikitext

Revision as of 19:07, 27 February 2015

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Synonyms and keywords: Etoposide-Vincristine-Adriamycin-Chlorambucil-Vinblastine-Procarbazine-Prednisone Regimen; EVA-ChlVPP Regimen

Overview

ChlVPP-EVA regimen refers to a regimen derived from the original MOPP-ABVD regimen, consisting of etoposide, vinblastine, doxorubicin (EVA) and chlorambucil, vincristine, procarbazine, prednisone (ABVD), used for the initial treatment of Hodgkin's lymphoma.^[1]^[2]

Regimen

Chl – Chlorambucil

V – Vincristine (Oncovin)

A – Doxorubicin (Adriamycin)

Indications

Hodgkin's lymphoma^[3]

References

↑ "NCI Thesaurus".
↑ "R-CHOP - National Cancer Institute".
↑ Rahemtulla A, Terpos E (2009). "Hodgkin's lymphoma". BMJ Clin Evid. 2009. PMC 2907766. PMID 21726488.CS1 maint: PMC format (link)

[1] "NCI Thesaurus".

[2] "R-CHOP - National Cancer Institute".

[pmid21726488-3] Rahemtulla A, Terpos E (2009). "Hodgkin's lymphoma". BMJ Clin Evid. 2009. PMC 2907766. PMID 21726488.CS1 maint: PMC format (link)

[1]

[2]

[3]

@@ Line 6: / Line 6: @@
 ==Overview==
-{{PAGENAME}} refers to a regimen derived from the original MOPP-ABVD regimen, consisting of etoposide, vinblastine, doxorubicin (EVA) and chlorambucil, vincristine, procarbazine, prednisone (ABVD), used for the initial treatment of Hodgkin's lymphoma.<ref>{{Cite web | title = NCI Thesaurus | accessdate =  | url = http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C63452 }}</ref><ref>{{Cite web | title = R-CHOP - National Cancer Institute | accessdate =  | url = http://www.cancer.gov/cancertopics/druginfo/R-CHOP }}</ref>
+{{PAGENAME}} refers to a regimen derived from the original MOPP-ABVD regimen, consisting of [[etoposide]], [[vinblastine]], [[doxorubicin]] (EVA) and [[chlorambucil]], [[vincristine]], [[procarbazine]], [[prednisone]] (ABVD), used for the initial treatment of Hodgkin's lymphoma.<ref>{{Cite web | title = NCI Thesaurus | accessdate =  | url = http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C63452 }}</ref><ref>{{Cite web | title = R-CHOP - National Cancer Institute | accessdate =  | url = http://www.cancer.gov/cancertopics/druginfo/R-CHOP }}</ref>
 ==Regimen==
@@ Line 25: / Line 25: @@
 ==Indications==
-* [[Hodgkin's lymphoma]]
+* [[Hodgkin's lymphoma]]<ref name="pmid21726488">{{cite journal| author=Rahemtulla A, Terpos E| title=Hodgkin's lymphoma. | journal=BMJ Clin Evid | year= 2009 | volume= 2009 | issue=  | pages=  | pmid=21726488 | doi= | pmc=PMC2907766 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21726488  }} </ref>
 ==References==